One of the largest and most comprehensive pediatric leukemia treatment centers in the country, offering individualized therapies for every type and phase of leukemia seen in infants, children, adolescents and young adults. Leukemia treatment is delivered by a highly competent, experienced and diverse staff of doctors and cancer researchers.
As a leader in the treatment and cure of pediatric cancer, Texas Children's Hospital has one of the premier children's leukemia centers in the country.
The Texas Children's Cancer Center's Leukemia Program provides comprehensive diagnosis, evaluation and management of pediatric patients with suspected or diagnosed leukemia or lymphoma. This encompasses patients with any of the following diseases: acute lymphblastic leukemia, acute myeloid leukemia, chronic leukemias and myelodysplastic syndromes.
There is strong emphasis on the development of innovative treatment regimens. All patients are considered for eligibility to participate in clinical trials, which are considered the standard of care for our patients.
- Cutting-edge therapies are utilized for all newly diagnosed patients as well as those with recurrent disease.
- Texas Children's Hospital is an internationally recognized hospital setting. Highly experienced doctors who are pediatric subspecialists in hematology-oncology, provide a comprehensive array of ancillary services, such as pediatric surgery, cardiology, infectious diseases, radiology, and dermatology.
- Family-centered care and emotional support are a primary focus of the program.
- The Leukemia Program interacts closely with the country's best pediatric cell and gene therapy and new drug development programs, which are also part of Texas Children's Cancer Center.
- An active research program focuses on understanding the underlying mechanisms of leukemia, as well as creating new therapeutic approaches to treat patients.
- The Leukemia Program is comprehensive, researching new means of diagnosing, monitoring, predicting behavior of, as well as treating and preventing childhood leukemia. It is multidisciplinary, utilizing experts from pediatric oncology, surgery, pharmacology, marrow and stem cell transplant, molecular oncology, cell and gene therapy, and radiation oncology.